Previous close | 24.02 |
Open | 24.07 |
Bid | 23.95 x 1300 |
Ask | 24.00 x 800 |
Day's range | 23.86 - 24.11 |
52-week range | 21.03 - 24.97 |
Volume | |
Avg. volume | 80,342 |
Market cap | 42.404B |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 3.06 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.41 (5.85%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
MetLife (MET) is introducing tailored products according to the market demand, enabling better market penetration and generating steady premiums.
Insurance giant MetLife rebounded late last year and is putting up strong sales and profit numbers. Additionally, MetLife stock is up 50% over the past year and just below a fresh buy point. The upgraded 82 RS Rating means that MetLife stock topped 82% of all stocks for price performance this past year.
The decent earnings reports have helped the sector to survive the market rout seen last month.